Dr. Singh is the Imaging Mass Cytometry (IMC) Program Lead for the Cellular Biomarker Group at GlaxoSmithKline, the global pharmaceutical company. He is a pioneer in the development of high-dimensional spatial discovery assays using IMC. As Scientist-in-Charge of Imaging Mass Cytometry at the USC Michelson Center Convergent Science Institute in Cancer – directed by renowned scientist Dr. Peter Kuhn – he designed and validated novel assays to detect and characterize circulating prostate cancer cells from liquid biopsy samples.
This person is not in the org chart
This person is not in any teams
This person is not in any offices